delayed

FDA-Approved Afrezza: An Inhaled Alternative to Injectable Insulin?

By: Elissa Tam, PharmD Candidate c/o 2015 - Patients with Type 1 or Type 2 diabetes who cannot control their…

12 years ago

Two New Agents for the Treatment of Obesity

By: Nathan Trustman, PharmD Candidate c/o 2013, AMSCOP at LIU - Obesity is defined as having a body mass index…

13 years ago

Purple Glove Syndrome

By: Sharon Janak, PharmD Candidate c/o 2013 - How can we distinguish between vascular injury and Purple Glove Syndrome (an…

13 years ago

Merck Settles Lawsuits Over Vytorin

By: Tasnima Nabi, Staff Editor - Merck & Co. will pay $688 million to settle two lawsuits filed in December…

13 years ago

New P2Y12 Antagonist on the Rise

By Nancy Rizkalla, PharmD candidate c/o 2015 -        Percutaneous coronary intervention (PCI) with subsequent stent implantation is a highly…

13 years ago

Giving a Second Chance: The Prescription Drug Abuse Epidemic on Long Island

By: Maria Sorbera, PharmD Candidate c/o 2013 at AMSCOP (LIU) - Author William S. Burroughs states in his novel, “The…

14 years ago

Studying Abroad: The Perspective From a Pharmacy Student

By: Shannon Tellier - When applying to St. John’s University College of Pharmacy and Health Sciences five years ago, I…

14 years ago

Understanding Diabetic Ketoacidosis

By: Mohamed Dungersi, Associate Student Editor -  What is diabetic ketoacidosis (DKA)? Diabetic ketoacidosis (DKA) is an acute complication of…

14 years ago

Effect of Intravenous Ondansetron on QT Interval Prolongation

By: Raymond Wu, Pharm.D. Candidate c/o 2013   The 5-hydroxytryptamine type 3 (5HT3) antagonists (e.g. ondansetron [Zofran®]) are commonly used…

14 years ago

Update: FTC Approves Medco and Express Scripts Merger

By: Mahdieh Danesh Yazdi, with Special Thanks to: Dr. Tomasz Jodlowski - In previous issues, we discussed an upcoming $29.1 billion…

14 years ago

Bydureon®: A Weekly Injection for Type 2 Diabetes Mellitus

By: Mohamed Dungersi - On January 27, the FDA approved Bydureon® (exenatide extended-release) for use in Type 2 Diabetes Mellitus…

14 years ago